One-Year Outcomes of Aflibercept in Recurrent or Persistent Neovascular Age-Related Macular Degeneration

PURPOSE: To evaluate 6-month and 1-year outcomes of every 8 weeks (Q8W) aflibercept in patients with resistant neovascular age-related macular degeneration (AMD). DESIGN: Retrospective, interventional, consecutive case series. METHODS: Retrospective review of patients with resistance (multiple recur...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Ophthalmol
Main Authors: Arcinue, Cheryl A., Ma, Feiyan, Barteselli, Giulio, Sharpsten, Lucie, Gomez, Maria Laura, Freeman, William R.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4329256/
https://ncbi.nlm.nih.gov/pubmed/25461263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2014.11.022
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki